Phase I NIH STTR awarded to Jeff Anker

January 26, 2021

Congratulations to Jeff Anker  for receiving funding for a Phase I NIH STTR proposal with SpineFrontier, Inc., “X-ray Visualized Interbody Spacer Indicating Biomechanical Load (X-VISIBL) Fusion Device” . Clemson gets $127,271 /1 yr going to John DesJardins (MPI) and him (co-I), and total grant with SpineFrontier is $252,127. Importantly this makes them eligible to apply for a Phase II proposal ($1.7 M /2 yr), and helps in developing a commercial product. The goal of the grant is R&D on an intervertebral spacer to detect spine fusion using standard X-ray imaging. It based on an issued patent that CURF licensed my startup company Aravis Biotech and SpineFrontier sublicensed the spine aspects of the patent from Aravis.

Related Posts